Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method.
作者： Vural Ozdemir , Werner Kalow , Bing-Kou Tang , Andrew Paterson , Scott Walker
DOI: 10.1097/00008571-200007000-00001
关键词:
摘要: … genetic component of variability in drug disposition. The aim of the present analysis was to assess the genetic … an underestimation of the genetic component in hepatic CYP3A4 activity …
lww.com
sci-hub.se 参考文章(56)
Elliot S. Vesell, Twin studies in pharmacogenetics. Human genetics. Supplement. pp. 19- 30 ,(1978) , 10.1007/978-3-642-67179-1_4
Grant R. Wilkinson, David G. Shand, A physiological approach to hepatic drug clearance Clinical Pharmacology & Therapeutics. ,vol. 18, pp. 377- 390 ,(1975) , 10.1002/CPT1975184377
Richard B. Kirn, Christoph Wandel, Brenda Leake, Mirjana Cvetkovic, Martin F. Fromm, Peter J. Dempsey, Mark M. Roden, Frank Belas, Ajai K. Chaudhary, Dan M. Roden, Alastair J. J. Wood, Grant R. Wilkinson, Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. Pharmaceutical Research. ,vol. 16, pp. 408- 414 ,(1999) , 10.1023/A:1018877803319
P. W. Kleyn, PHARMACOGENOMICS:Genetic Variation as a Guide to Drug Development Science. ,vol. 281, pp. 1820- 1821 ,(1998) , 10.1126/SCIENCE.281.5384.1820
M F Fromm, D Busse, H K Kroemer, M Eichelbaum, Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin Hepatology. ,vol. 24, pp. 796- 801 ,(1996) , 10.1002/HEP.510240407
Simon E. Ball, JoAnn Scatina, John Kao, Geraldine M. Ferron, Richard Fruncillo, Philip Mayer, Ira Weinryb, Marco Guida, Penelope J. Hopkins, Natalie Warner, Jeff Hall, Population distribution and effects on drug metabolism of a genetic variant in the 5′ promotor region of CYP3A4 Clinical Pharmacology & Therapeutics. ,vol. 66, pp. 288- 294 ,(1999) , 10.1016/S0009-9236(99)70037-8
P.A. Soons, H.C. Schoemaker, A.F. Cohen, D.D. Breimer, Intraindividual Variability in Nifedipine Pharmacokinetics and Effects in Healthy Subjects The Journal of Clinical Pharmacology. ,vol. 32, pp. 324- 331 ,(1992) , 10.1002/J.1552-4604.1992.TB03843.X
Urs A. Meyer, Overview of enzymes of drug metabolism Journal of Pharmacokinetics and Biopharmaceutics. ,vol. 24, pp. 449- 459 ,(1996) , 10.1007/BF02353473
A. Lindholm, S. Henricsson, M. Lind, R. Dahlqvist, Intraindividual variability in the relative systemic availability of cyclosporin after oral dosing. European Journal of Clinical Pharmacology. ,vol. 34, pp. 461- 464 ,(1988) , 10.1007/BF01046702
Paul B. Watkins, Noninvasive tests of CYP3A enzymes. Pharmacogenetics. ,vol. 4, pp. 171- 184 ,(1994) , 10.1097/00008571-199408000-00001